Abstract Background Acute myeloid leukemia (AML) is a genetically heterogeneous disease in which glutamine (Gln) contributes to AML progression. Therefore. this study aimed to identify potential prognostic biomarkers for AML based on Gln metabolism-related genes. Methods Gln-related genes that were differentially expressed between Cancer Genome Atlas-based AML and normal samples were ... https://www.roneverhart.com/Sheepshead-Bay-Boats-2-Brooklyn-NY/